Castleview Partners, LLC Csl LTD Transaction History

Castleview Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$87.94 - $101.67 $65,075 - $75,235	-740 Reduced 50.27%	732 $67,000
Q2 2022 Aug 16, 2022	BUY	$87.94 - $101.67 $128,128 - $148,133	1,457 Added 9713.33%	1,472 $135,000
Q1 2022 May 16, 2022	SELL	$85.56 - $107.12 $1.37 Million - $1.71 Million	-15,960 Reduced 99.91%	15 $1,000
Q4 2021 Feb 17, 2022	BUY	$97.41 - $116.74 $1.5 Million - $1.8 Million	15,380 Added 2584.87%	15,975 $1.69 Million
Q2 2021 Aug 17, 2021	BUY	$100.62 - $116.66 $59,868 - $69,412	595 New	595 $63,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.